Skip to main content
. 2017 Aug;14(3):319–326. doi: 10.20892/j.issn.2095-3941.2017.0024

2.

Relation of β-catenin expression to other clinicopathological variables

Variables β-catenin expression, n (%) χ2 P
0 + ++ +++
Age, years 2.379 0.498
 <30 3 (13.6) 3 (13.7) 15 (68.2) 1 (4.5)
 >30 35 (26.7) 17 (12.9) 69 (52.6) 10 (7.6)
Gender 0.727 0.867
 Female 27 (23.8) 14 (12.3) 63 (55.7) 9 (7.9)
 Male 11 (27.5) 6 (15.0) 21 (52.5) 2 (5.0)
Location 4.971 0.548
 Hemispheric 29 (29.2) 13 (13.1) 50 (50.5) 7 (7.0)
 Skull base 8 (20.0) 4 (10.0) 25 (62.5) 3 (7.5)
 Spinal 1 (7.2) 3 (21.4) 9 (64.3) 1 (7.1)
Histologic type 60.234 <0.001
 Transitional 5 (8.3) 8 (13.3) 42 (70.0) 5 (8.3)
 Meningotheliomatous 11 (26.8) 1 (2.4) 24 (58.5) 5 (12.1)
 Psammomatous 3 (25.0) 0 8 (66.6) 1 (8.4)
 Fibroblastic 3 (27.3) 5 (45.4) 3 (27.3) 0
 Atypical 11 (61.1) 5 (27.8) 2 (11.1) 0
 Microcystic 1 (33.3) 0 2 (66.7) 0
 Metaplastic 1 (50.0) 0 1 (50.0) 0
 Angiomatous 0 1 (33.3) 2 (66.7) 0
 Malignant 3 (100.0) 0 0 0
Histologic grade 40.522 <0.001
 Grade 1 23 (17.5) 14 (10.7) 83 (63.4) 11 (8.4)
 Grade 2 12 (63.1) 6 (31.5) 1 (52.6) 0
 Grade 3 3 (100.0) 0 0 0
Recurrence 21.798 <0.001
 No 27 (20.3) 14 (10.5) 81 (60.9) 11 (8.2)
 Yes 11 (55.0) 6 (30.0) 3 (15.0) 0
Brain invasion 37.116 <0.001
 No 23 (17.6) 14 (10.7) 83 (63.4) 11 (8.4)
 Yes 15 (68.2) 6 (27.3) 1 (4.5) 0